PCG
WST icon

Private Capital Group’s West Pharmaceutical WST Stock Holding History

Private Capital Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$66K Sell
219
-22
-9% -$7.16K 0.05% 383
2022
Q1 		$99K Sell
241
-5
-2% -$1.96K 0.02% 401
2021
Q4 		$115K Sell
246
-1
-0.4% -$430 0.02% 382
2021
Q3 		$105K Buy
247
+15
+6% +$6.32K 0.02% 417
2021
Q2 		$83K Sell
232
-66
-22% -$21.8K 0.02% 483
2021
Q1 		$84K Sell
298
-95
-24% -$27.2K 0.02% 443
2020
Q4 		$111K Sell
393
-174
-31% -$48.8K 0.02% 468
2020
Q3 		$156K Sell
567
-220
-28% -$58.2K 0.03% 334
2020
Q2 		$179K Sell
787
-19
-2% -$3.73K 0.04% 306
2020
Q1 		$123K Buy
806
+136
+20% +$20.9K 0.03% 355
2019
Q4 		$100K Sell
670
-12
-2% -$1.75K 0.02% 446
2019
Q3 		$97K Buy
682
+244
+56% +$33.6K 0.02% 491
2019
Q2 		$43K Sell
438
-235
-35% -$27.7K 0.01% 742
2019
Q1 		$74K Buy
673
+206
+44% +$21.4K 0.01% 597
2018
Q4 		$46K Buy
467
+23
+5% +$2.5K 0.01% 712
2018
Q3 		$54K Sell
444
-53
-11% -$5.94K 0.01% 685
2018
Q2 		$49K Buy
497
+7
+1% +$644 0.01% 706
2018
Q1 		$43K Buy
490
+148
+43% +$13.8K 0.01% 754
2017
Q4 		$34K Buy
+342
New +$33.5K 0.01% 846

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Private Capital Group's WST Position: Q2 2022 in Review

Private Capital Group reduced its West Pharmaceutical (WST) stake by 9.1% in Q2 2022, selling an estimated $7.16K and leaving 219 shares worth $66K. The position accounts for 0.05% of the portfolio, ranked #383.

Private Capital Group first reported a position in WST in Q4 2017 and has held it in 19 quarters since. The position peaked at $179K in Q2 2020. 655 funds tracked by Wall St. Rank hold WST as of Q2 2022.

  • Private Capital Group held 219 shares of West Pharmaceutical worth $66K as of Q2 2022.
  • Private Capital Group sold 22 West Pharmaceutical shares in Q2 2022, an estimated $7.16K.
  • West Pharmaceutical made up 0.05% of Private Capital Group's portfolio in Q2 2022, its #383 holding.
  • Private Capital Group first reported a position in West Pharmaceutical in Q4 2017 and has held it in 19 quarters since.
  • Private Capital Group's West Pharmaceutical position peaked at $179K in Q2 2020.
  • 655 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.